Thursday, October 08, 2009

From Twitter 10-07-2009





Tweets copied by twittinesis.com


buzz this

Wednesday, October 07, 2009

The Web 2.0 Internet and the Clinical Practice of Oncology

By Daniel D. Karp, MD, Ronald H. Blum, MD, Clifford Hudis, MD,L. Michael Glode, MD, and Allard J. Snijders, PhD (see below for more information on the authors)

Overview: This article reviews the emerging trends of the new Web 2.0 generation of websites, their potential use in the field of oncology, and American Society of Clinical Oncology (ASCO) and non-ASCO Internet resources for medical oncologists, on the basis of the authors’ extensive experience and use of the Internet in their own education and oncology practices.


CLICK HERE TO DOWNLOAD THE COMPLETE ARTICLE.

From the M.D. Anderson Cancer Center, Houston TX (Dr. Karp); the Beth Israel Cancer Center, New York, NY (Dr. Blum); the University of Colorado Cancer Center, Aurora, Colorado (Dr. Glode); the Memorial Sloan-Kettering Cancer Center (Dr. Hudis) and the American Society of Clinical Oncology Integrated Media Department (Dr. Snijders).

IMPORTANT NOTE:
This article was provided to me for distribution with expressed permission from Daniel D. Karp, MD, M.D. Anderson Cancer Center. Please do not duplicate or re-post without obtaining permission from Dr. Karp. You can write to him at the follow e-mail:
dkarp@mdanderson.org.
buzz this

Health 2.0 on the Rise – 35% of U.S. Adults Use Social Media for Medical Information

Manhattan Research’s Cybercitizen Health™ study details how patients engage in social media for health – Webinar October 14, 11am

October 7, 2009, New York, NY – About 35% of the U.S. adult population uses social media for health and medical purposes in 2009, according to pharmaceutical and healthcare market research company Manhattan Research’s Cybercitizen Health™ v9.0. These 80 million Health 2.0 Consumers create or consumer content on health blogs, message boards, chat rooms, health social networks and health communities, and patient testimonials.

Though the Health 2.0 market grew substantially in the past year, it still represents just one of many online resources consumers use to get health information. Furthermore, survey results suggest that not all user-generated content is influential. In 2009, a minority of consumers report they are influenced by Health 2.0 media. But Health 2.0 Consumers are an important group to watch, especially for brand teams focused on the therapeutic segments that rely on user-generated content more than others, such as patients suffering from mental health conditions, fibromyalgia, and ADD/ADHD.

“While there’s no doubt that social media is a critical area for pharmaceutical marketers, it’s still just one piece of the overall consumer media mix,” said Monique Levy, Senior Director of Research at Manhattan Research, “Our consumer research shows that user-generated content is an important influential resource for certain therapeutic segments, suggesting social media is more of a priority for some brands than others.”

Register for Cybercitizen Health™ Webinar

President Mark Bard will discuss today’s digital health market and its effect on marketing and consumer engagement in an upcoming webinar on October 14, 2009 at 11am EDT. The session is a preview of the rich consumer market data and insights available to clients of the Cybercitizen Health™ v9.0 market research and strategic advisory service and will offer tips and trends to help healthcare marketers determine an optimal media mix when targeting patient audiences. Topics include health-related media consumption across traditional and alternative resource channels, use of social media for health, emerging media formats like online video, use of major online health networks like WebMD and Everyday Health, and mobile health applications.

Cybercitizen Health™ 2009: Connecting with Patients Online for Health
Wednesday, October 14, 11:00 – 11:30 AM EDT
Register here: https://www2.gotomeeting.com/register/968476938

About Cybercitizen Health™ v9.0

Cybercitizen Health™ v9.0 was fielded in Q3 2009 among 8,600 U.S. adults (ages 18+). The consumer market research and strategic advisory service focuses on how consumers use new media and technology for health and its impact on treatment and product decisions. In addition to the data, clients receive strategic deliverables including research reports, client briefings, and access to the Manhattan Research analyst team to answer specific questions. Broad consumer research can also be segmented to derive insight into a wide range of eHealth preferences and behaviors for over 100 therapeutic groups. For additional product and subscription information, please visit http://www.manhattanresearch.com/cch.

About Manhattan Research

Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com, email sales@manhattanresearch.com or call 1.888.680.0800.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

###

All company, brand, or product names contained in this document may be trademarks or
registered trademarks of their respective holders.

buzz this

From Twitter 10-06-2009





Tweets copied by twittinesis.com


buzz this

Tuesday, October 06, 2009

Gel Health 2009 Conference, 10/22 in NYC

Source: GelHealth

Gel Health will explore the patient experience - how to improve it, and who's doing it, in a variety of organizations and companies. Like any Gel conference, we'll tackle the theme from a broad array of perspectives.

Gel Health will explore the patient experience - how to improve it, and who's doing it, in a variety of organizations and companies. Like any Gel conference, we'll tackle the theme from a broad array of perspectives.

A good primer on patient experience is this video of Bridget Duffy's talk at Gel 2008

Gel Health will be held on Thursday and Friday, October 22 and 23, 2009 at Scandinavia House, Park Avenue and 38th Street in Manhattan.

Gel Health tickets are available at for $499.

The Gel (Good Experience Live) conference series, a seven-year-old event curated by Mark Hurst, is launching a new healthcare event - Gel Health - a conference focused on the patient experience.

Confirmed GEL Health 2009 speakers (so far):

  • Dr. Bridget Duffy, Chief Experience Officer, Cleveland Clinic
  • Dr. Robert Martensen, Author, A Life Worth Living; lecturer, Dept. of Global Health and Social Medicine, Harvard Medical School
  • Cathy Salit, Working with Johns Hopkins oncology nurses via Performance of a Lifetime
  • Dan Ford, Patient advocate
  • Dr. Javette Orgain, Family physician; Chairperson, Illinois State Board of Health
  • Dr. John La Puma, Author, ChefMD's Big Book of Culinary Medicine
  • Dr. Jim Withers, Founder, Operation Safety Net
  • Dr. Mark Pochapin, Director, Jay Monahan Center for Gastrointestinal Health
  • Michael Christensen, Co-Founder and Creative Director of the Big Apple Circus and founder of Clown Care
  • Olie Westheimer, Founder, Brooklyn Parkinson Group; cofounder, "Dance for PD" with Mark Morris Dance Group
  • Dr. Sharon Krumm, Director of Nursing, Johns Hopkins Kimmel Cancer Center
  • Dr. Sigall Bell, Beth Israel Deaconess Medical Center
  • Bill Brownstein, Founder, Kids RX

buzz this

Physician Smartphone Adoption Rate to Reach 81% in 2012

Date: October 5, 2009
Source: Manhattan Research

REPORT TITLE: "Physicians in 2012: The Outlook for On Demand, Mobile, and Social Digital Media"

NEW YORK, NY – October 5, 2009 – Physician smartphone adoption rates will experience significant growth over the next few years. Currently, 64% of U.S. physicians own smartphones, but this will increase to 81% penetration in 2012, according to the latest physician report from pharmaceutical and healthcare company Manhattan Research. “Physicians in 2012: The Outlook for On Demand, Mobile, and Social Digital Media,” is part of the company’s Taking the Pulse® market research and strategic advisory service. The report looks at how physician use of emerging technologies such as mobile and social media will evolve in 2012 and serves as a guide for manufacturers and publishers looking to leverage imminent digital opportunities.

While the last few years saw strong growth in the share of physicians starting to use digital media for work, the next couple of years will see the evolution of a more mature and proficient physician audience. With this shift, the Internet will become physicians’ primary professional resource. Mobile will become even more indispensable to physicians as they start to expand the range activities they perform on these devices to include administrative tasks and patient monitoring.

“By 2012, all physicians will walk around with a stethoscope and a smart mobile device, and there will be very few professional activities that physicians won’t be doing on their handhelds. Physicians will be going online first for the majority of their professional needs and will be regularly pulling online resources into patient consultations,” said Monique Levy, Senior Director of Research at Manhattan Research. “Understanding the shifts that are occurring is essential for manufacturers, especially as many are reevaluating their sales model overall at this time.”


For more on this report, click here.
buzz this

From Twitter 10-05-2009



  • 05:14:16: Last weeks news from comScore - "FDA Warning Letters Caused Dramatic Decline in Sponsored Link Exposures": http://tr.im/AJJq
  • 05:20:38: Fascinating paper on twitter as a powerful word-of-mouth tool: http://tr.im/AJKV
  • 05:31:07: BIO-RAD's video channel rocks... Amazing to see "The PCR" song has surpassed 500,000 views! http://tr.im/AJOT
  • 05:38:41: 367 Hospitals in US Now Use Social Media: http://tr.im/AJRm
  • 05:41:02: Five Google Sidewiki Examples in the Pharma, Retail, Insurance, and Electronics Categories: http://tr.im/AJSd
  • 06:16:35: Online Pharma Ads: Consumers Need More Information: http://tr.im/AJTe
  • 06:16:41: 87+ of the best digital campaigns over last 12 months: http://tr.im/AK5K (THANK U @Jaeselle)
  • 06:22:49: @Pitch360 @pharmaguy RE: drop in sponsored search (A) How much $ did google & search media cos lose? (B) if/how/when will pharma spend it?
  • 08:35:27: So, so cool. BIONIC EYE: another incredible iphone app. that showcases the future of mobile augmented reality: http://tr.im/AL0H
  • 08:47:35: Grin of the day: "I GOOGLE MYSELF", hands-down funniest online video I have seen all year: http://tr.im/AL3F (rated R for language)
  • 09:16:57: ADAGE: Apple, Microsoft Are Megabrand Kingpins in Social Radar Index: http://tr.im/ALhx
  • 09:21:39: ADAGE: "What E-mail 2.0 May Look Like", RE: Google Wave - http://tr.im/ALjv
  • 09:39:07: BREAKING NEWS: FTC Clamps Down On Ad Testimonials - no more "I lost 100 lbs in 1 month", subtitle: "results may vary": http://tr.im/ALpK
  • 16:46:01: SIDEBAR WIKI BLOCKER (a test): Can you see my posts? Can you post? RT if it works: http://tr.im/AO0A
  • 16:48:17: Can PHARMA COs block people from posting on GOOGLE'S SIDEWIKI? See 4 yourself: http://tr.im/AO0A
  • 16:54:37: @MaverickNY but can u see my posts?
  • 16:59:31: @MaverickNY : I will wait 2 see what others say. If indeed this works, then coding sites to block sidewiki is EXTREMELY simple (& legit)
  • 17:01:27: THE GOOLE SIDEWIKI CHALLENGE: is anyone able to post a comment on my test site, or view others' comments? LMK. http://tr.im/AO0A
  • 17:11:21: @MaverickNY : I think it's good it's not TOTALLY lost. The difference is now people must visit your profile 2 see it, right? Like any blog.
  • 17:12:16: @blogaceutics : don't see it. Do you (upon re-visiting site)? Does anyone else?
  • 17:14:39: @blogaceutics : Miguel, what browser are you using -- perhaps it will still appear somewhere.
  • 17:17:48: RT @MaverickNY: @scobleizer what do you think of @skypen's neat sidewiki blocker? http://tr.im/AO0A :-) CREDIT GOES 2 ROMANIAN PROGRAMMER.
  • 17:23:54: SIDEWIKI BLOCKER, script by Catalin Ionescu of Romania. Costs $27. Takes minutes 2 install. Could B obsolete 2morrow: http://tr.im/AObZ
  • 17:36:40: @mrgunn : Not saying 2 buy this--may not B a long-term/viable solution, but it shows it's POSSIBLE 2 block SW, that's all I wanted 2 know ;)
  • 17:39:57: @mrgunn : but isn't greasemonkey a script that runs on individual's browser s-- a website owner would still not have control... right?
  • 17:43:21: @mrgunn : AHA, I see what you mean. And then someone would have to develop a code to block that. Good times!
  • 17:47:45: @mrgunn : Point taken. Will b interesting 2 see how the next several weeks play out regarding all this.
  • 17:57:32: FAST COMPANY: "How Social Media is Upending the Enterprise" - http://tr.im/AOkM (via @bernardmoon)
  • 18:01:33: Nice BNET post RE: Nielsen's recent report on ad spending growth on social networks: http://tr.im/AOla (via @bernardmoon)
  • 18:15:18: CONGRATS! RT @GSW_Worldwide: GSW Worldwide awarded 16 Rx Club Awards of Excellence!
  • 18:32:42: @blogaceutics @MaverickNY - Where there's a will, there's a way. Course, firefox + script = very small % of users. Still, you're right!
  • 21:13:29: Really love this post by @bernardmoon, some gr8 wisdom here: "Kevin Compton's 5 Rules for Success": http://tr.im/AP4O


Tweets copied by twittinesis.com


buzz this

Monday, October 05, 2009

comScore: FDA Warning Letters Caused Dramatic Decline in Sponsored Link Exposures

Pharmaceutical Manufacturers Reevaluate How to Reach Consumers during the Search Process

Source: comScore

RESTON, VA, October 1, 2009 – comScore, Inc. (NASDAQ: SCOR), a leader in measuring the digital world, today released the results of a study of changes in search engine marketing in the pharmaceutical industry as a result of the FDA warning letters distributed in March 2009. Using comScore data, the study found that sponsored link exposures to U.S. Internet users declined more than 50 percent immediately after the FDA warning letters were issued to pharmaceutical manufacturers concerning the exclusion of fair balance language in sponsored link advertising.

On March 26, 2009, the Division of Drug Marketing, Advertising, and Communications (DDMAC) of the U.S. Food and Drug Administration (FDA) sent warning letters to 14 major pharmaceutical manufacturers identifying specific brands as being in violation of FDA fair balance guidelines. The letters stated that sponsored link advertisements for specific drugs were misleading due to the exclusion of risk information associated with the use of the drug.

At the urging of the warning letters, many pharmaceutical companies temporarily removed their sponsored link ads for these identified brands as well as many other brands not specifically mentioned in the letters. As a result, sponsored link exposures for pharmaceutical brands experienced a dramatic decline as manufacturers redesigned their strategies to ensure compliance with the letters.

FDA Letters Cause an Immediate 59 Percent Drop in Sponsored Link Exposures





An analysis of exposure to branded URLs within comScore’s data revealed that substantial declines occurred immediately following the letters being sent on March 26. Sponsored link exposures dropped 59 percent from 10.5 million during the week ending March 29 to 4.3 million during the week ending April 5. Declines in sponsored link exposures not only occurred in the weeks immediately following the letters, but continued over the next several months, plummeting 84 percent overall from March to June.

Vanity and unbranded link exposures also experienced a decline, on average, across brands during the same period, although these methods were not under scrutiny in the FDA letters. Unbranded sites, which give additional information on the condition and treatment but do not directly promote the brand drug, declined 35-percent March to June to slightly more than one million exposures. Vanity URLs, which make no mention of a specific brand while generically describing a health condition but then redirect to the brand or drug’s website, declined 11 percent in June to 3.2 million average exposures versus March.

Although the use of vanity and unbranded URLs saw growth for certain individual brands after the letters, the overall decline in vanity and unbranded URL exposures demonstrates that searchers for information on a specific treatment or drug brand may not find the health-related information they are searching for as readily as they did prior to the guidance.

“The FDA letters changed not only how pharmaceutical manufacturers are marketing online, but what consumers are being exposed to when they search for health information,” said John Mangano, vice president of marketing solutions for comScore. “Independent of what is happening on the regulatory front, we see continued increases in consumers turning to the Internet to research health conditions, treatments and drugs. It is important that marketers and the FDA find a middle ground that meets the spirit of the FDA guidelines and is supportable in the various emerging online media.”

About comScore

comScore, Inc. (NASDAQ: SCOR) is a global leader in measuring the digital world and preferred source of digital marketing intelligence. For more information, please visit www.comscore.com/companyinfo.

Contact:
Sarah Radwanick
Senior Analyst
comScore, Inc.
+1 312 775 6538
buzz this

Sunday, October 04, 2009

From Twitter 10-03-2009



  • 07:58:48: @gorode : I hope that all is OK. re: worst news of your life.


Tweets copied by twittinesis.com


buzz this

Saturday, October 03, 2009

From Twitter 10-02-2009



  • 06:49:31: Medical Marketing & Media cover story on Social Media features Juvenation.org, community for type1 #diabetes: http://tr.im/Ar7o
  • 15:15:42: Medical Marketing & Media: "Lilly delves into social media for oncology art contest": http://tr.im/Au8H


Tweets copied by twittinesis.com


buzz this

Thursday, October 01, 2009

Patient-Targeted Messaging for Emerging Multiple Sclerosis Agents Needs to Highlight Efficacy and Preservation of Quality of Life

Surveyed Neurologists Perceive the Efficacy of Merck Serono's Rebif Nearly As Equivalent to that of Biogen Idec's Tysabri, According to a New Report From Decision Resources

Press Release
Source: Decision Resources
On Wednesday September 30, 2009, 8:14 am EDT

WALTHAM, Mass., Sept. 30 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that patient-targeted messaging for emerging multiple sclerosis oral agents will need to provide high-level information regarding the efficacy and preservation of quality of life and forego catchy and/or short taglines highlighting oral dosing. The knowledgeable multiple sclerosis patient population is likely to already be informed about oral dosing and will want information regarding efficacy and safety so that they can readily compare these new agents to the efficacy and safety of currently available agents.

"Based on our survey of multiple sclerosis patients, messages from Biogen Idec's Avonex were among the most appealing to patients because they highlight the drug's ability to slow the progression of disability and its ability to reduce the frequency of relapses. Messages highlighting patient support programs (such as Bayer's Betaseron) or needle size (such as Teva Pharmaceutical's Copaxone) were among the least appealing," stated Amanda Puffer, analyst at Decision Resources.

The new report entitled Brand Perceptions in Multiple Sclerosis also finds that surveyed neurologists perceive the efficacy of Merck Serono's safer Rebif nearly as equivalent to that of Biogen Idec's Tysabri. Despite Tysabri's efficacy in clinical trials, this shows that neurologists do not perceive its superiority in delaying disability progression to be sufficient to offset its safety drawbacks.

"One of our most surprising findings was the fact that surveyed neurologists perceive Tysabri to be only slightly more efficacious than Rebif. Even though Tysabri's efficacy is superior to that of Rebif's, it is well accepted that neurologists are hesitant to prescribe Tysabri because of the risk of progressive multifocal leukoencephalopathy (PML) associated with it," added Ms. Puffer.

PML is a rare and potentially fatal central nervous system infection occurring in immune-compromised individuals.

The report contains primary research with 101 U.S. neurologists and 253 U.S. patients. Key brands included in the primary research consist of Avonex, Tysabri, Rebif, Betaseron, Copaxone, Genentech's Rituxan, Roche's CellCept and generics.

About Brand Perception Series

Decision Resources' Brand Perception Series quantitatively analyzes physician and patient brand perception and message resonance. The findings are driven by extensive primary research and offer clients an unbiased, comprehensive, cost-effective solution to understanding the full competitive brand landscape.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

buzz this

From Twitter 09-30-2009



  • 06:30:44: UCB Pharma launches new support & advocacy program Crohn'sAdvocate - claims 2 CONNECT people, but misses SOC MED opp: http://tr.im/Adt3


Tweets copied by twittinesis.com


buzz this

Wednesday, September 30, 2009

New Program Strips Stigma From Crohn's Disease and Unites Community

ATLANTA, Sept. 29 /PRNewswire/ -- Launched today, a new support and advocacy program called Crohn'sAdvocate(TM) takes a full 360 degree approach to connecting, educating and empowering the half a million Americans living with Crohn's disease. Through a team of inspiring advocates, forum events across the country, and a free, quarterly magazine, the program is designed to connect people on the same journey and break the stigmas associated with Crohn's disease. This comprehensive, educational program offers people living with Crohn's with resources, guidance and support locally and nationally, offline and online at CrohnsAdvocate.com.

To view the Multimedia News Release, go to: http://www2.prnewswire.com/mnr/ucb/39965/

To view Website: http://www.CrohnsAdvocate.com

Crohn's disease is a chronic, progressive and debilitating inflammatory bowel disease that results in an inflammation of the gastrointestinal (GI) tract. Most Americans living with Crohn's disease often feel isolated and limit social activities because of the constant pain and fatigue they experience, as well as the fear of an immediate need to find a public restroom. Often the embarrassing nature of the disease forces those afflicted to battle Crohn's disease alone, as people find it difficult to share their experience with others.

"This is an exciting and much-needed resource for the Crohn's community," noted Marla Dubinsky, MD, contributor to the Crohn'sAdvocate magazine and Director of the Pediatric Inflammatory Bowel Disease Center at Cedars-Sinai Medical Center in Los Angeles, Calif. "Crohn'sAdvocate is a program developed to strip away the stigma of secrecy often inherent with diagnosis and open doors to communicating with others about the condition."

The program is comprised of four key components:

  • Crohn'sAdvocate Team: At the heart of the program is an inspiring team of advocates. They are empowered individuals who share their personal journeys with others living with Crohn's.
  • Crohn'sAdvocate Magazine: A free, quarterly publication chronicles the journeys of people on the frontlines of Crohn's disease: those living with Crohn's, their healthcare providers, family and friends.
  • Crohn'sAdvocate Forums: Local educational symposiums across the country connect people living with Crohn's disease with an Advocate who reveals his/her personal journey with the disease, a leading gastroenterology expert and supportive materials.
  • CrohnsAdvocate.com: A dynamic Web site provides informative news about the program, an opportunity to preview magazine articles and subscribe to the publication and venue-specific information for the local forums.
  • The cornerstone of the program is the magazine, entitled Crohn'sAdvocate. Now in its second issue, the educational centerpiece has a youthful, energetic design that aims to provide readers with a moving, informative and fun reading experience, unique from any other publication dedicated to the disease. Thirteen contributors connected to Crohn's, such as Los Angeles-based comedian Ben Morrison and former National Hockey League (NHL) player Kevin Dineen, have ensured that this issue, entitled "Crohn's at a Crossroads," is filled with practical information on everyday living, inspirational patient-centric stories about life transitions, as well as useful news and insights for people with Crohn's, especially those making a life change. A pilot issue was published in April 2009. The magazine is available through doctors' offices nationwide and online at CrohnsAdvocate.com.
"When I was first diagnosed with Crohn's 23 years ago, I was worried about how my life would change, what people would think and how it would affect my career," said Dineen, who currently coaches the American Hockey League's Portland Pirates. "I have found that it is so helpful to meet others who are going through what you are because they understand- that's why it is important to have a program like this."

To connect people who often feel isolated, the Crohn'sAdvocate team is traveling across the country to eight cities this fall speaking about their personal journeys with the disease. Each Advocate is paired with a leading gastroenterologist who provides an overview of the disease and ways to manage it. The Crohn'sAdvocate Forums were piloted in the spring of 2009 and have already connected more than 100 people affected by Crohn's disease.

The Crohn'sAdvocate program was created and is supported by biopharmaceutical company UCB. The program was created in response to the needs expressed by the Crohn's community including a stronger connection with others, information and support related to health and well-being and education and encouragement to address disease management.

To download an issue of Crohn'sAdvocate magazine, learn about a Crohn'sAdvocate Forum event, or view stories and pictures of those involved in the program, go to CrohnsAdvocate.com.

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a biopharmaceutical company dedicated to the research, development and commercialization of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Employing approximately 10,000 people in over 40 countries, UCB produced revenue of 3.6 billion euro in 2008. UCB is listed on Euronext Brussels (Symbol: UCB) . U.S. headquarters is located in Atlanta, Ga.

Forward looking statement

This press release contains forward-looking statements based on current plans, estimates and beliefs of management. Such statements are subject to risks and uncertainties that may cause actual results to be materially different from those that may be implied by such forward-looking statements contained in this press release. Important factors that could result in such differences include: changes in general economic, business and competitive conditions, effects of future judicial decisions, changes in regulation, exchange rate fluctuations and hiring and retention of its employees.
buzz this

From Twitter 09-29-2009





Tweets copied by twittinesis.com


buzz this

Tuesday, September 29, 2009

NIH Wants Help Improving Public Input

Source: HDM Breaking News, September 24, 2009
by Joseph Goedert

The National Institutes of Health has issued a request for information on ways to better receive input from consumers and improve communication with the public.

NIH is the primary federal agency conducting and supporting biomedical and behavioral research. The RFI is in response to President Obama's call for greater transparency, public participation and collaboration in federal decision making.

"The RFI will provide insight and better understanding of the health information needs and information-seeking behaviors of NIH health consumer audiences," according to the document. "Information gathered will assist the agency in developing and disseminating health, medical and scientific information to a broader variety of audiences. The agency anticipates using new outreach strategies and tools, from community-level outlets to Internet-based social media. Members of the public as well as organizations are invited and encouraged to participate in this public input opportunity."

The RFI seeks information on the following topics:

* the current state and range of health information-seeking behaviors and trends;
* the range of health information of interest to the public;
* how the public accesses and uses health information; and
* barriers that might impede NIH's ability to communicate with health consumers.

NIH published the request for information on Sept. 23 in the Federal Register, available at www.gpoaccess.gov/fr/index.html. Responses are due by Dec. 31, 2009.

buzz this

From Twitter 09-28-2009





Tweets copied by twittinesis.com


buzz this

Saturday, September 26, 2009

From Twitter 09-25-2009



  • 06:20:59: Think it's viable? RT: @pharmaguy If only this were NOT a mock site created by u. re paharmaco solciting AEs via widget: http://bit.ly/U9P9v
  • 07:28:50: PhRMA 08 revd guidelines stated all print ads shld incl FDA Medwatch 800# & Web URL for AE reporting? No rec. 4 websites. WTF. @pharmaguy
  • 07:38:21: Health Leaders Media: "Health System Uses Social Media to Recruit Physicians': http://tr.im/zIiu (@seaboardhcs)
  • 07:40:41: RT @pharmaguy: Put this FDA widget on ur brand.com site & ur SM AE reporting worries r over: http://pic.gd/774fa9 (JST MOCK UP by @skypen!)
  • 07:47:54: Other option: "click 2 talk/chat"- staff call center; pharmacos pay yearly fee, run by 3rd party, feeds real-time database, MDs can access.
  • 09:08:20: Perhaps a combo: phone tree, trained operators, & RNs - with a triage algorhithm. RT @RandstadPharma: who staffs the call center?
  • 09:54:30: Voice of San Diego: "My Grandmother Out-Tweets Your Biotech": http://tr.im/zJ6t (@davidwash @Peterpitts) #fdasm
  • 09:58:02: Thanks 4 the summary Ellen! RT @ellenhoenig: Pharma Marketers: A Few Takeaways RE: PharmaMed Conference. http://bit.ly/GajK1 #pharmamed
  • 11:05:47: RT @shwen: @pharmaguy: "Pharma Hot or Not": http://twitpic.com/j36qu
  • 11:10:35: Thanks 4 FF & ditto! FOLLOW THESE GUYS: @cheyennejack @pharmaguy @chickalishus @RandstadPharma @shwen #followfriday #followpharma
  • 11:30:09: @fardj I just report the news. AMERICA VOTED and U R 1 of "PHARMA'S HOTTEST BLOGGERS" @shwen @pharmaguy: http://twitpic.com/j36qu
  • 11:36:31: THANK YOU @JNJComm for the #followfriday . I would do the same back but I think *everyone* already follows you! :)
  • 11:42:38: Re-tweet a gr8 post. 5 new followers. Tweet something semi-intelligent. 10 new followers. Have @pharmaguy say ur good looking. PRICELESS.
  • 11:47:56: And stack the deck? U have an unfair advantage as is! RT: @pharmaguy I could have given you a MUCH better photo had I known abt it. ;-)
  • 11:50:35: And next time u go 2 hooters...RT: @pharmaguy @skypen I live vicariously through u! Nxt time u go to Italy I wnt daily posts & flickr updts!
  • 12:00:41: Interesting use of twitter, hashtag & SMS by pharma: http://tr.im/zJL5 (@AstellasUS)
  • 12:02:34: I sense #jealousy :) RT @a0k: the growing #bromance btw @skypen & @pharmaguy is so awkward & so amusing. #pharma
  • 12:23:35: @a0k had no idea #bromance was a hashtag :)
  • 13:07:44: This will come back 2 haunt me. I just know it! :) RT: @pharmaguy @a0k I live right outside the city of "brotherly love" ya know.
  • 13:55:03: Thnx 4 this. RT @JNJComm: RT @SusannahFox: In case you're a fan: @Pew_Internet on Slideshare http://bit.ly/20ztHe
  • 13:58:09: RT @JaeSelle: "6 Steps 2 Getting Your Healthcare Social Media Idea Approved" http://su.pr/1jUzvS RT @jonmrich
  • 14:00:44: Does any1 know whether twt invitations 2 join some1's "Mafia Family" r auto-spam or real, authorized invites? (My uncle Vincenzo is pissed!)
  • 14:07:19: Both. RT @rlewis: Fabio what tools do u use 2 deploy client SM? Updates 2 each platform independently or managed thru aggregator tool?
  • 14:39:27: Diff. aggregators 4 diff. purposes. 4 core aggregation, Yahoo! Pipes rocks. @rlewis
  • 14:40:22: @rlewis know OF shoutlet, never used. Just took a quick look. Seems interesting. DM me 4 further discussion :)
  • 17:04:31: Pharma Marketing Blog: "Some Pharma Marketers Can't See the Unbranded SM Forest 4 the Branded SM Tree": http://tr.im/zL9r (via @durbaniak)
  • 19:10:33: Worth the grin. "The Stupidest Article About Social Media Ever": http://tr.im/zLDy (@comprendia @Zee @maverickny)


Tweets copied by twittinesis.com


buzz this

Friday, September 25, 2009

Health System Uses Social Media to Recruit Physicians

Source: Health Leaders Media

Written by Marianne Aiello, for HealthLeaders Media, September 23, 2009


When Geisinger Health System in Danville, PA, was having trouble recruiting gastroenterologists earlier this year, Cathy Connolley knew it was time for an innovative strategy.

"When recruiting gastroenterologists we traditionally would do print ads in different medical journals and direct mail," says Connolley, Geisinger's associate vice president of marketing. "But this time, we weren't getting the types of responses that we were looking for."

So the Geisinger marketing team worked with Zero-In Recruitment Marketing, a Bloomsburg, PA, firm, to create a social media physician recruitment campaign.

Zero-In began integrating social media into many of their clients' recruitment efforts because it realized that the majority of physicians use the Internet to conduct their job search. According to a 2008 New England Journal of Medicines study, 71% of respondents said they hunted for jobs online. And the popularity of Sermo, a social networking site just for physicians, gives marketers some insight into how doctors spend their time online.

Geisinger wanted to develop a convenient, cost-effective way to communicate with physicians, Connolley says. "So we sat down with Zero-In and they walked us through what it would take to put a Facebook page up and direct gastroenterologists who met the criteria we were looking for to our page—and that tactic outpaced our direct mail approach and our email blasts."

Geisinger and Zero-In launched a Facebook page in January, which includes photos, recruitment event information, and links to the health system's site.

Attracting followers on Twitter
Seaboard Health Care Search, a physician recruitment firm based in Nashville, also worked with Zero-In to promote their brand via social media. But Seaboard focused their efforts on a different channel: Twitter.

"We're in a marketplace that is now shifting to people who are very young," says CEO William Herrington. "I'm always looking at how to position my organization to take advantage and get to physicians-in-training earlier."

Herrington's experience with physicians taught him that they have very little time to keep on top of medical news and other hot topics, so Twitter was the best medium for Seaboard to disseminate that information to busy physicians while building its brand.

The key to building a successful Twitter campaign is to provide people with useful information and not only promote your business, says Todd Cole, recruitment marketing specialist at Zero-In.

"You run a big risk of alienating your population by using social media as sales tools," he says. "We've been using Twitter to share information that's valuable to physicians and physician organizations and making Seaboard's name synonymous with those."

Seaboard's Twitter account posts links to articles that physicians may find interesting from a variety of sources.

"We're trying to develop an educational aspect to let physicians know what's going on," Herrington says. "We want to get to the point where they don't have to use us and we can still educate them and they will have a positive viewpoint on Seaboard healthcare because we're actually giving them something."

Turning fans and followers into employees
In addition to promoting positive brand awareness, social media sites are effective marketing tools because there are many ways to track their results. Though Geisinger and Seaboard's campaigns are in the early stages, both organizations have already seen an impact on their recruitment efforts.

Geisinger, for example, sent out a direct mail piece to a list of gastroenterologists with a link to a job listing page. Just four people who received the mailing visited to the Web page. When Geisinger posted the same job-page link on their Facebook page, 17 people clicked on it.

The health system has since hired three gastroenterologists, one of which can be directly attributed to the success of the Facebook page.

Seaboard has heard a lot of positive feedback from physicians and clients about their Twitter account, Herrington says.

"People are actually clicking on the information we're putting out and sharing it with the people who follow them," Cole says. "We can track the trend and the effectiveness of what we're putting up and the traffic that we're getting through URL-shorteners. We're sprinkling the business information in right now, and eventually we can make it a 60/40 split [between news and recruitment information]."

Before embarking on a social media recruitment campaign, healthcare organizations must commit resources to update the sites at least daily and decide how to bring useful information to their target audience, Cole says.

"The first thing people need to realize is it's not meant to be a job board," he says. "If you're going to take it on by yourself, you have to make sure you have someone who's going to dedicate time to it daily. You have to make sure your light is always on so people know to stop by."

buzz this

From Twitter 09-24-2009



  • 12:07:34: BREAKING NEWS: John Mack (@pharmaguy) gives up bIogging to pursue new entrepreneurial venture in the t-shirt business: http://tr.im/zDmi
  • 13:49:49: THANK U EILEEN! RT @EileenOBrien: @slarcker @skypen Nice quotes in the PharmaExec social media article: http://bit.ly/v5qof
  • 16:25:30: Nice :)RT: @slarcker pharmexec: "An Open Conversation," quoting me & my @Digitas_Health colleagues RE: social in pharma! http://bit.ly/PE7cW
  • 17:59:06: @pharmaguy -- AE reporting, Universal FDA Widget ... John, remember this idea? http://tr.im/zEZ3
  • 18:07:46: Marc Monseau explains Y TWTR has not changed how J&J communicates: http://tr.im/zF1g @stevewoodruff @eileenobrien @EngagementStrat @JNJComm
  • 18:13:03: No idea why it requires FIREFOX instead of working in Google's own Chrome??? RT @ellenhoenig: RT @PhilBaumann: Google's SideSwipe/SideWiki
  • 18:16:33: What you must do 2 prep 4 FDA Public Hearing on Social Media: http://tr.im/zF5q - As always, thank U Mark (@eyeonfda) - GR8 post 4 industry
  • 18:25:02: 2Day's Headline from @Pharmaguy: "Pharma Spends More DTC $$ on Web vs. Newspapers"; 2012 Headline: "Pharma Spends More $$ on Web. Period."
  • 18:28:40: RT @Roche_com: Interesting poll results on @mhuckman ‘s blog about twitter and the biopharma industry: http://www.cnbc.com/id/32987936
  • 18:51:46: @mhuckman RE: ur post- actually Lilly IS on Twitter, just not in a corp way. They sponsored medscape tweets from lung conf & @LlyOncOnCanvas


Tweets copied by twittinesis.com


buzz this

Wednesday, September 23, 2009

From Twitter 09-22-2009





Tweets copied by twittinesis.com


buzz this

Tuesday, September 22, 2009

From Twitter 09-21-2009





Tweets copied by twittinesis.com


buzz this

Monday, September 21, 2009

From Twitter 09-20-2009





Tweets copied by twittinesis.com


buzz this

Sunday, September 20, 2009

From Twitter 09-19-2009





Tweets copied by twittinesis.com


buzz this

Saturday, September 19, 2009

From Twitter 09-18-2009



  • 17:25:43: MUST-READ BREAKING NEWS: The FDA calls 1st ever PUBLIC HEARING 2 discuss DRUG PROMOTION using INTERNET & SOCIAL MEDIA: http://tr.im/z65H
  • 19:20:57: THANX 4 RT! @xpetit @brianreid @cramermarketing @ edwardaten @maverickNY @heldincontempt @digitalbulldog @MiriamETucker: http://tr.im/z65H
  • 19:29:21: FDA concedes: "Special characteristics of Web 2.0 & other technologies may require agency 2 provide additional guidance.": http://tr.im/z65H
  • 19:44:24: FDA calls public hearing 2 discuss Drug Promotion via Internet & Social Media 2 gather data & possbly inform new guidance: http://tr.im/z65H
  • 21:11:20: Brilliant!!! RT: @PhilBaumann @shwen Let's see how close I'll be on # 61, 62 & 64 re: FDA & Twitter - http://bit.ly/3TvNvb


Tweets copied by twittinesis.com


buzz this

Friday, September 18, 2009

BREAKING NEWS: The FDA calls for a public hearing to discuss promotion of FDA-regulated medical products using the Internet and social media tools

This could perhaps be one of the most significant developments in healthcare marketing that I have witnessed in the past 10 years. The FDA is calling an official hearing to discuss medical product communications -- specifically in the context of the Internet, Web 2.0, and Social Media. This is a must read for anyone interested in helping shape the future of our industry.

The following statement, an extract from the notice, perfectly captures the significance of this event.

The FDA writes:

"The continually evolving nature of the Internet, including Web 2.0 and social media tools, as well as their expansion to applications such as mobile technology, have raised questions and concerns over how to apply existing regulations to promotion in these newer media. FDA is evaluating how the statutory provisions, regulations, and policies concerning advertising and promotional labeling should be applied to product-related information on the Internet and newer technologies.

Although the agency believes that many issues can be addressed through existing FDA regulations, special characteristics of Web 2.0 and other emerging technologies may require the agency to provide additional guidance to the industry on how the regulations should be applied."

# # #


# # #

Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools; Notice of Public Hearing

AGENCY:
Food and Drug Administration, HHS.

ACTION:
Notice of public hearing; request for comments.

SUMMARY:
The Food and Drug Administration's (FDA's) Center for Drug Evaluation and Research (CDER), in collaboration with FDA's Center for Biologics Evaluation and Research (CBER), Center for Veterinary Medicine (CVM), and Center for Devices and Radiological Health (CDRH), is announcing a public hearing to discuss issues related to the promotion of FDA-regulated medical products (including prescription drugs for humans and animals, prescription biologics, and medical devices) using the Internet and social media tools.

FDA is seeking participation in the public hearing and written comments from all interested parties, including, but not limited to, consumers, patients, caregivers, health care professionals, patient groups, Internet vendors, advertising agencies, and the regulated industry. This meeting and the written comments are intended to help guide FDA in making policy decisions on the promotion of human and animal prescription drugs and biologics and medical devices using the Internet and social media tools. FDA is seeking input on a number of specific questions but is interested in any other pertinent information participants in the hearing would like to share.

Dates and Times: The public hearing will be held on November 12 and 13, 2009, from 8 a.m. to 5 p.m. each day. Submit written or electronic registration by close of business on October 9, 2009. Written and electronic comments will be accepted until February 28, 2010.

Location: The public hearing will be held at the National Transportation Safety Board Conference Center, 429 L'Enfant Plaza, SW., Washington, DC 20594, 2023146305; Metro: L'Enfant Plaza station on the yellow, green, orange, and blue lines; see:


(FDA has verified the Web site address, but FDA is not responsible for any changes to the Web site after this document publishes in the Federal Register.)

buzz this

From Twitter 09-17-2009





Tweets copied by twittinesis.com


buzz this

Thursday, September 17, 2009

From Twitter 09-16-2009



  • 12:33:47: New Manhattan Research report: Oncologists visit pharma sites & post content more than ave. HCP: http://tr.im/yTba (via @manhattanresear)


Tweets copied by twittinesis.com


buzz this

Wednesday, September 16, 2009

Manhattan Research: Oncologists eHealth Trends

Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician

Source: Manhattan Research Press Release


Manhattan Research Specialist Segmentation Module Explores How Oncologists Use the Internet and Other Technologies for Professional Purposes and Treatment Decisions

September 16, 2009, New York, NY – Oncologists are more likely than the overall population of U.S. physicians to visit pharmaceutical, biotech, and device corporate and product websites on a regular basis, according to pharmaceutical and healthcare market research company Manhattan Research. In fact, almost seventy percent of oncologists visit product websites monthly or more often. Additionally, oncologists are three times more likely than physicians overall to be high-frequency contributors of online health-related content. The findings are derived from Manhattan Research’s study of physician adoption and use of the Internet and other technologies. The company’s physician market research can be segmented to derive insights into over twenty target physician specialties.

The field of oncology is rapidly changing, and physicians in this specialty rely on digital resources to receive the most up-to-date clinical and product news at the moment they need the information. While the sales rep is still undoubtedly important to many oncologists, manufacturers are now realizing the importance of supplementing in-person details with relevant online brand content that these specialists can access on-demand. For example, PfizerOncology.com from Pfizer offers useful videos, extensive product information, and patient education materials via an easy-to-navigate portal.

“The insight that oncologists are ‘above average’ in the digital realm is no surprise to the enlightened brand manager with an eye towards the future – a future in which reps are simply part of the promotional mix and not the center of it,” said Mark Bard, President of Manhattan Research. “The findings also highlight the need to further refine a professional strategy based on the needs of individual physician specialist segments. Clearly, companies can’t use a one-size-fits-all approach when addressing a physician audience online.”

Physician Specialist Segmentation Modules

Manhattan Research provides comprehensive analyses of over twenty physician specialist groups. Each Specialist Segmentation Module is an in-depth view of a particular market’s adoption and use of the Internet and other technologies for clinical, treatment, and product decisions and focuses heavily on tactical execution. The segmentation modules provide clients with the necessary market data and insights to make better informed decisions during brand planning and to connect with a particular specialist group through digital strategies.

Physician specialist module topics include interactive detailing, Web 2.0, pharmaceutical customer service portals, tech-enabled sales reps, search engines, online and offline professional information sources, email use and opportunity, patient interaction and education, digital health infrastructure, and mobile technology profile.

Complimentary Specialist Digital Report Card

Are you curious as to how your target specialist group stacks up to the digital adoption trends of physicians overall? To request a complimentary digital report card of your specialist segment, and to view a list of available physician specialist segmentation modules and topics, please visit http://www.manhattanresearch.com/products/Specialist_Segmentations

For additional segmentation module product and purchasing information, please contact sales@manhattanresearch.com or call 1.888.680.0800, ext 2.

About Manhattan Research

Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm. We conduct annual research studies covering eHealth trends among physicians and consumers, including Taking the Pulse®, Taking the Pulse® Nurses, Taking the Pulse® Europe, Taking the Pulse® Asia, Cybercitizen Health™, Cybercitizen Health™ Europe, ePharma Consumer®, and ePharma Physician®. Broad consumer and physician research is complemented by targeted analysis among more than 100 consumer therapeutic segments and 25 physician specialist segments. For information, please contact sales@manhattanresearch.com, call 1.888.680.0800, or visit http://www.manhattanresearch.com.

Stay up to date on the latest eHealth trends through our e-newsletter and social networks –
About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.

###

All company, brand, or product names contained in this document may be trademarks or

registered trademarks of their respective holders.
buzz this

Saturday, September 12, 2009

From Twitter 09-11-2009





Tweets copied by twittinesis.com


buzz this

Friday, September 11, 2009

From Twitter 09-10-2009





Tweets copied by twittinesis.com


buzz this

Friday, September 04, 2009

From Twitter 09-03-2009





Tweets copied by twittinesis.com


buzz this

Thursday, September 03, 2009

Yahoo Tests Microblogging Service

Source: Mediapost (Online Media Daily)
by Mark Walsh

In its latest effort to catch up in social networking, Yahoo has quietly introduced a microblogging service that looks like its answer to Twitter. An English-language version of the offering dubbed Yahoo Meme was launched in alpha this week following the rollout of versions in Spanish and Portuguese in recent months, according to TechCrunch.

The service lets users post videos, photos and other content accompanied by short descriptions and create a comment thread beneath each entry. People can also follow others on Yahoo Meme, as with Twitter and Tumbler, and track their posts through a personal dashboard. Users can also "repost" anyone's entries to their own meme.

Yahoo explains in the "About" section of the site that Meme is intended to let people quickly and easily share content without having to be part of any specific social network. (Although you do have to be registered on Yahoo.) The company also believes it has ideas on how to do these things "in better ways than what we see on other sites."

TechCrunch, however, was not impressed after testing the service, saying it "seems lacking in its features and its potential to surpass its competitors." Both TechCrunch and paidContent point out that Yahoo has a spotty track record with social networking, having shuttered projects like Yahoo Mash and SpotM in India less than a year after its launch.

That's not to mention the closing of Yahoo 360 in May, and Yahoo in April announcing plans to pull the plug on GeoCities, the forerunner of sites like Facebook and MySpace that Yahoo acquired a decade ago for $3.6 billion. (At least the company isn't still throwing around that kind of money on attempts to gain ground in social media.)

With Twitter established as the Internet's social wire service, and Facebook in hot pursuit, Yahoo trying to create its own microblogging alternative looks like another quixotic effort in the social space. Has anyone been clamoring for Yahoo to build a Twitter-killer?

The biggest advantage that a service like Yahoo Meme could have over Twitter is reliability. Twitter has become notorious for frequent service outages, with its "Fail Whale" graphic, appearing whenever the site is overloaded, emerging as the company's unofficial logo.

If nothing else, Yahoo has shown it can handle major traffic spikes, as when news of Michael Jackson broke and the Web portal stayed up and running as other sites such as Google and Twitter buckled under the surge in volume. TechCrunch reported Wednesday that Twitter had hired ex-Google exec and Feedburner founder Dick Costolo as COO, presumably to help tackle its downtime issues.

If only Yahoo could hire a Mr. Fix-It for its social networking woes.

buzz this

From Twitter 09-02-2009



  • 16:35:42: New health-focused semantic search engine debuts "HealthBase": http://tr.im/xKR8 (@techcrunch finds small bug: "Causes of AIDS: Jew". WTF?)
  • 16:36:47: Very cool (and rare) indeed! RT @jlefevere: just had a quick call with @skypen...I love it when like minds meet.
  • 17:43:20: DC launches multimedia HIV campaign"Ask for The Test": http://tr.im/xL3R (via @PozMagazine)


Tweets copied by twittinesis.com


buzz this

Wednesday, September 02, 2009

DC Launches Multimedia HIV Testing Campaign

Source: POZ

On August 29, DC officials launched a $225,000 multimedia campaign encouraging residents to get an HIV test, The Associated Press reports. Advertisements—which can already be seen on television—feature people holding up signs that read, “Ask for the Test.”

According to the article, the campaign will include additional television spots as well as print, outdoor and radio ads. It also allows DC residents to use text messaging to find the nearest HIV testing site. The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria will team with pharmaceutical giant Pfizer to encourage doctors to offer HIV tests to their patients.

“Hopefully within a short period of time, people are going to understand that they’re not going to go to the doctor without asking for an HIV test,” said Mayor Adrian Fenty, who views HIV/AIDS as the city’s “greatest public health challenge.”

The testing initiative is the first phase of DC’s five-year HIV effort. This winter, the campaign will focus on encouraging residents to talk to their partners about their HIV status. The campaign will then focus on promoting condom use.

According to a report released earlier this year, at least 3 percent of DC residents are already living with the virus.

Check out the campaign's Website: www.DCTakesonHIV.com.

buzz this

From Twitter 09-01-2009





Tweets copied by twittinesis.com


buzz this

Tuesday, September 01, 2009

From Twitter 08-31-2009





Tweets copied by twittinesis.com


buzz this

Saturday, August 29, 2009

From Twitter 08-28-2009





Tweets copied by twittinesis.com


buzz this

Thursday, August 27, 2009

From Twitter 08-26-2009



  • 10:05:42: CRZY! RT @EileenOBrien: Fascinating! 35% of those surveyed by about.com wld fill Rx w/out 1st doing research online http://twurl.nl/07hpa2
  • 16:43:40: U r vry welcome! RT: @NatBourre @skypen Thanks for including me in yr `24` list. I am delightfully surprised 2 see my name there.


Tweets copied by twittinesis.com


buzz this

Wednesday, August 26, 2009

From Twitter 08-25-2009



  • 07:17:41: @Boehringer Ingelheim launches 1st 2 YouTube Channels, including "Parkinson's Matters": http://tr.im/x3VE (via Skoko)
  • 11:23:29: U R WELCOME! Love ur tweets! RT @bradatpharma: @skypen : Thanks for putting me in your list... that's an amazing crowd to be included in :)
  • 11:23:43: U R WELCOME, Wendy. RT @WendyBlackburn: Thanks @skypen ... Honored to be among your 24 "PharmaTweeps" http://bit.ly/fxmlv Cool dashboard.
  • 11:28:00: The 24: Pharma Twitterati worth following! http://tr.im/x3UA
  • 11:29:23: The 24: @shwen @pharmaguy @swoodruff @jonmrich @@whydotpharma @bradatpharma @eileenobrien @wendyblackburn @kevinfrench: http://tr.im/x3UA
  • 11:30:43: The 24: @kevinkruse @leonardkish @heldincontemp @maverickny @natbourre @philbaumann @richmeyer @ellenhoenig: http://tr.im/x3UA
  • 11:31:46: The 24: @pitch360 @jaeselle @mkmackey @durbaniak @angel189 @eyeonfda: http://tr.im/x3UA
  • 11:37:16: 24-hours of non-stop pharma tweets! RT @heldincontempt: Thanks, @skypen, for including me on your "24" -- I am honored! http://is.gd/2ygB0
  • 11:39:59: One small catch, Twitter API hates feeding 24 streams to the masses all at once... so sometimes the dashboard goes blank. Moronic ;)
  • 16:21:28: Great post Mark! "New Offerings by Pharma on YouTube": http://tr.im/x6U6 (@eyeonFDA)
  • 18:11:26: Had 2 make room 4 others. RT @kevinkruse: @skypen Wow, very cool & honored 2 be in such gr8 company. But Fabio, why aren't U in the #1 spot?


Tweets copied by twittinesis.com


buzz this

Tuesday, August 25, 2009

From Twitter 08-24-2009





Tweets copied by twittinesis.com


buzz this

Monday, August 24, 2009

From Twitter 08-23-2009





Tweets copied by twittinesis.com


buzz this